SUDĖTINĖ TERAPIJA NAUDOJANT ANTI CD20 ANTIKŪNĄ SU BCL-2 INHIBITORIUMI IR MDM2 INHIBITORIUMI

• 收藏
• 分享

专利权人:

F. Hoffmann-La Roche AG

发明人:

KLEIN, Christian,HERTING, Frank,DANGL, Markus

申请号：

LT16725104

公开号：

LT3302549T

申请日:

2016.05.23

申请国别(地区):

LT

年份:

2019

代理人:

摘要：

The present invention is directed to the combination therapy of an anti-CD20 antibody with a Bcl-2 inhibitor and a MDM2 inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with a type I anti-CD20 antibody or an afucosylated humanized B-Ly1 antibody and a Bcl-2 inhibitor and a MDM2 inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/